Although this is the first time that IFITM3 was demonstrated to be a predictor for lymph node metastatic recurrence of ESCC patients, replication studies with different parameters and prospective and multicenter randomized studies are also needed to verify this prognostic significance. The gene discussed is IFITM3; the disease is esophageal squamous cell carcinoma.